GB201219111D0 - Composition for parental administration, method for production and use thereof - Google Patents

Composition for parental administration, method for production and use thereof

Info

Publication number
GB201219111D0
GB201219111D0 GBGB1219111.0A GB201219111A GB201219111D0 GB 201219111 D0 GB201219111 D0 GB 201219111D0 GB 201219111 A GB201219111 A GB 201219111A GB 201219111 D0 GB201219111 D0 GB 201219111D0
Authority
GB
United Kingdom
Prior art keywords
composition
production
parental administration
parental
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1219111.0A
Other versions
GB2507289A (en
GB2507289B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SOLOVYEV NIKOLAY V
Original Assignee
SOLOVYEV NIKOLAY V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SOLOVYEV NIKOLAY V filed Critical SOLOVYEV NIKOLAY V
Priority to GB1219111.0A priority Critical patent/GB2507289B/en
Priority to GB1506139.3A priority patent/GB2523481B/en
Publication of GB201219111D0 publication Critical patent/GB201219111D0/en
Publication of GB2507289A publication Critical patent/GB2507289A/en
Application granted granted Critical
Publication of GB2507289B publication Critical patent/GB2507289B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/616—Echinodermata, e.g. starfish, sea cucumbers or sea urchins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB1219111.0A 2012-10-24 2012-10-24 Composition for parenteral administration, method for producing and use thereof Active GB2507289B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1219111.0A GB2507289B (en) 2012-10-24 2012-10-24 Composition for parenteral administration, method for producing and use thereof
GB1506139.3A GB2523481B (en) 2012-10-24 2012-10-24 Composition for parental administration, method for producing and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1219111.0A GB2507289B (en) 2012-10-24 2012-10-24 Composition for parenteral administration, method for producing and use thereof

Publications (3)

Publication Number Publication Date
GB201219111D0 true GB201219111D0 (en) 2012-12-05
GB2507289A GB2507289A (en) 2014-04-30
GB2507289B GB2507289B (en) 2015-09-09

Family

ID=47359403

Family Applications (2)

Application Number Title Priority Date Filing Date
GB1219111.0A Active GB2507289B (en) 2012-10-24 2012-10-24 Composition for parenteral administration, method for producing and use thereof
GB1506139.3A Active GB2523481B (en) 2012-10-24 2012-10-24 Composition for parental administration, method for producing and use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1506139.3A Active GB2523481B (en) 2012-10-24 2012-10-24 Composition for parental administration, method for producing and use thereof

Country Status (1)

Country Link
GB (2) GB2507289B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105866261A (en) * 2016-03-24 2016-08-17 中国药科大学 Metabolism marker group used for diagnosing and differentiating stable angina pectoris and acute coronary syndrome
CN105876137A (en) * 2016-05-13 2016-08-24 菏泽海诺知识产权服务有限公司 Feed for panopea abrupta and preparation method thereof
FR3079142B1 (en) * 2018-03-23 2020-11-27 Matieres Premieres Int VETERINARY COMPOSITION CONTAINING SUPEROXIDE DISMUTASE AND AT LEAST ONE PROTEIN HYDROLYSATE RICH IN BIOASSIMILABLE PEPTIDES

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2098106C1 (en) * 1994-02-08 1997-12-10 Центральный научно-исследовательский институт эпидемиологии РФ Method for diagnosing myasthenia
US7074433B2 (en) * 2001-03-30 2006-07-11 Council Of Scientific And Industrial Research Process for the cure and control of Diabetes mellitus using natural products from Perna viridis
JP2003024008A (en) * 2001-07-19 2003-01-28 Mikimoto Pharmaceut Co Ltd Food
US6905710B2 (en) * 2001-08-31 2005-06-14 Council Of Scientific And Industrial Research Pharmaceutical composition useful for inhibition of osteoclast formation and a process for the extraction of mussel hudrolysate from indian green mussel
US6960451B2 (en) * 2002-02-06 2005-11-01 Green Earth Industries Proteolytic fermenter
CN100467030C (en) * 2005-11-07 2009-03-11 上海新药研究开发中心 Trachyostracous mussel extract and its prepn and use
JP2008037766A (en) * 2006-08-02 2008-02-21 Kyosei Seiyaku Kk Angiotensin i converting enzyme inhibitor, and food material and food product having antihypertensive action
JP2009035525A (en) * 2007-08-03 2009-02-19 National Institute Of Advanced Industrial & Technology Melanogenesis inhibitor
KR100904631B1 (en) * 2007-09-05 2009-07-03 경상대학교산학협력단 Preparation of functional hydrolysates from oyster using transglutaminase
KR101027604B1 (en) * 2009-06-30 2011-04-06 강릉원주대학교산학협력단 A composition comprising the dry powder, polar solvent extract and the insoluble residue of Anthocidaris crassispina as an active ingredient showing liver detoxification and antioxidant activity

Also Published As

Publication number Publication date
GB2523481A (en) 2015-08-26
GB2507289A (en) 2014-04-30
GB201506139D0 (en) 2015-05-27
GB2507289B (en) 2015-09-09
GB2523481B (en) 2016-03-16

Similar Documents

Publication Publication Date Title
HK1200880A1 (en) Magnesium-zinc-calcium alloy, method for production thereof, and use thereof
HK1205161A1 (en) Polymer, process and composition
HK1200879A1 (en) Magnesium-aluminum-zinc alloy, method for the production thereof and use thereof
SG11201406026TA (en) Magnesium-zinc-calcium alloy, method for production thereof, and use thereof
IL231591A (en) Substituted benzylindazoles, process for their manufacture and uses thereof
SG11201500948RA (en) Barrier film, method of making the barrier film, and articles including the barrier film
EP2881395A4 (en) Piperazinotrizole compound, preparation method therefor, and use thereof in drug preparation
EP2826765A4 (en) Production method for 2,3,3,3-tetra-fluoropropene and 1,1-difluoroethylene
IL236463A0 (en) Bifluorodioxalane-amino-benzimidazole compounds, compositions comprising same, processes for producing same and uses thereof
EP2822998A4 (en) Compatibilized composition, method for the formation thereof, and article comprising same
EP2939662A4 (en) Pharmaceutical composition with improved stability, containing temozolomide, and preparation method therefor
ZA201407708B (en) Confectionery composition, method therefor, and associated confectionery articles
EP2915819A4 (en) Antibody and antibody composition production method
EP2924042A4 (en) Bis- -carboline compound and preparation method, pharmaceutical composition and use thereof
EP2873701A4 (en) Organic-inorganic complex, and forming composition thereof
EP2813495A4 (en) 2-arylbenzofuran-7-formamide compounds, preparation method and use thereof
EP2857001A4 (en) Method for producing tablet, and tablet
EP2978011A4 (en) Method for manufacturing complex, and composition
EP2921548A4 (en) Refined-coal production method, and refined-coal production device
EP2836551A4 (en) Compatibilized composition, method for the formation thereof, and article comprising same
EP2805956A4 (en) Gambogenic acid derivatives, preparation method and application thereof
EP2933290A4 (en) Composition for forming complex, complex formed therefrom, and composition for oral administration including said complex
EP2862937A4 (en) Method for producing phospholipid-containing composition, and phospholipid-containing composition
EP2874994A4 (en) 3,5,n-trihydroxy-alkanamide and derivatives: method for making same and use thereof
EP2873681A4 (en) Isoprene copolymer, and manufacturing method for same

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20171102 AND 20171108